Blood transcriptomics of preclinical Alzheimer’s Disease patients

Marcelo Madrid de Bittencourt, Marco De Bastiani, Pamela C.L. Ferreira, Eduardo R. Zimmer, João Batista Teixeira da Rocha · 2025

Read Blood transcriptomics of preclinical Alzheimer’s Disease patients by Marcelo Madrid de Bittencourt, Marco De Bastiani, Pamela C.L. Ferreira, Eduardo R. Zimmer, João Batista Teixeira da Rocha (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11713915.txt.

Description

Alzheimer's disease starts silently, years before memory fails, and blood tests might catch the earliest shifts. Madrid de Bittencourt and co-authors compare gene activity in blood from 63 people with no symptoms, sorted by spinal fluid markers into no pathology, amyloid only, and amyloid plus tau groups. They hunt for the core gene programs that change at each stage.

Hundreds of genes shifted at each step, yet only 29 changed across all comparisons. Amyloid alone tracked with immune and cell-skeleton programs, while the double-positive group added inflammation signals. Both pathologies disturbed cell cycle and DNA repair systems. The authors read the blood changes as a window on preclinical disease.

Catalog record

CREATORMarcelo Madrid de Bittencourt, Marco De Bastiani, Pamela C.L. Ferreira, Eduardo R. Zimmer, João Batista Teixeira da Rocha
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE3 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11713915

Browse the full library · About the Tower of Babel